Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis
Authors
Keywords
-
Journal
BMC GASTROENTEROLOGY
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-12
DOI
10.1186/s12876-020-01334-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- Epidemiological feature of NAFLD from 1999 to 2018 in China
- (2020) Jianghua Zhou et al. HEPATOLOGY
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Identification of 8-miRNAs as biomarkers for nonalcoholic fatty liver disease
- (2019) Yuanjie Yu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2019) Ke Pu et al. BMC GASTROENTEROLOGY
- miRNAs and NAFLD: from pathophysiology to therapy
- (2019) Monika Gjorgjieva et al. GUT
- Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
- (2019) Changzhou Cai et al. Canadian Journal of Gastroenterology and Hepatology
- Lipotoxic Hepatocyte‐Derived Exosomal miR‐192‐5p Activates Macrophages via Rictor/Akt/FoxO1 Signaling in NAFLD
- (2019) Xiao‐Lin Liu et al. HEPATOLOGY
- The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications
- (2019) Klieser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation
- (2019) Denisa Erhartova et al. PLoS One
- MicroRNA-451 and Genistein Ameliorate Nonalcoholic Steatohepatitis in Mice
- (2019) Mailin Gan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
- (2019) Olfat M. Hendy et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients
- (2018) Dan Ye et al. LIFE SCIENCES
- Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers
- (2018) Mireia López-Riera et al. Scientific Reports
- miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2018) Chang-Hai Liu et al. JOURNAL OF HEPATOLOGY
- Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
- (2018) Jorge-Luis Torres et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
- (2018) Mark A. Febbraio et al. Cell Metabolism
- miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
- (2018) Paola Dongiovanni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
- (2018) Fernando Bril et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
- (2017) Charlie C. Park et al. GASTROENTEROLOGY
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- New trends on obesity and NAFLD in Asia
- (2017) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients
- (2017) Jee-Fu Huang et al. PLoS One
- Benefit–risk of intraoperative liver biopsy during bariatric surgery: review and perspectives
- (2017) Sandrine Barbois et al. Surgery for Obesity and Related Diseases
- Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity
- (2016) Lei Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease
- (2016) Xiao Lin Liu et al. Journal of Digestive Diseases
- Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
- (2016) Noel C. Salvoza et al. PLoS One
- Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population
- (2016) Xiao-Lin Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis
- (2015) Philip P. Becker et al. PLoS One
- Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease
- (2015) Jiexia Ding et al. Scientific Reports
- Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
- (2014) Carlos J Pirola et al. GUT
- Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
- (2014) Ceri A. Fielding et al. IMMUNITY
- A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
- (2014) Youwen Tan et al. PLoS One
- Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
- (2013) R. Kwok et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
- (2013) Kenneth Cusi et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
- (2012) György Baffy et al. JOURNAL OF HEPATOLOGY
- miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease
- (2012) Rui E. Castro et al. JOURNAL OF HEPATOLOGY
- Genetic variant inPNPLA3is associated with nonalcoholic fatty liver disease in China
- (2011) Yiling Li et al. HEPATOLOGY
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- An apoptosis panel for nonalcoholic steatohepatitis diagnosis
- (2010) Tarek I. Abu-Rajab Tamimi et al. JOURNAL OF HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now